Amarastesia Overview
- Year Founded
-
2024
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$700K
- Investors
-
5
Amarastesia General Information
Description
Developer of a uterine access device designed to enable safe and minimally invasive gynecological procedures. The company offers atraumatic device design, precision access capabilities, enhanced procedural safety features, enabling gynecologists, healthcare providers to perform uterine interventions with reduced patient discomfort and improved clinical outcomes.
Contact Information
Website
www.amarastesia.comCorporate Office
- Places Des Sciences
- Courroux
- Switzerland
Corporate Office
- Places Des Sciences
- Courroux
- Switzerland
Amarastesia Timeline
Amarastesia Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Grant | 01-May-2026 | $700K | Completed | Pre-Clinical Trials | ||
| 5. Accelerator/Incubator | 01-Jan-2025 | Completed | Pre-Clinical Trials | |||
| 4. Accelerator/Incubator | 01-Jan-2025 | Completed | Pre-Clinical Trials | |||
| 3. Accelerator/Incubator | 07-Oct-2024 | Completed | Pre-Clinical Trials | |||
| 2. Angel (individual) | $50K | $50K | Completed | Pre-Clinical Trials | ||
| 1. Accelerator/Incubator | 01-Jan-2024 | Completed | Pre-Clinical Trials |
Amarastesia Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Amarastesia Patents
Amarastesia Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12446870-B2 | Device for atraumatic passageway of instruments with or without dilation | Active | 04-Jun-2021 | ||
| US-20240099709-A1 | Device for atraumatic passageway of instruments with or without dilation | Active | 04-Jun-2021 | ||
| US-11904122-B1 | Disposable pass through dilator and method of use | Active | 04-Jun-2021 | A61M29/00 |
Amarastesia Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Amarastesia Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Innosuisse | Government | Minority | ||
| Basel Area Business & Innovation | Accelerator/Incubator | |||
| InnovX (Bucharest) | Accelerator/Incubator | |||
| DayOne Accelerator | Accelerator/Incubator | |||
| CNY Biotech Accelerator | Accelerator/Incubator |
Amarastesia FAQs
-
When was Amarastesia founded?
Amarastesia was founded in 2024.
-
Where is Amarastesia headquartered?
Amarastesia is headquartered in Courroux, Switzerland.
-
What is the size of Amarastesia?
Amarastesia has 4 total employees.
-
What industry is Amarastesia in?
Amarastesia’s primary industry is Surgical Devices.
-
Is Amarastesia a private or public company?
Amarastesia is a Private company.
-
What is the current valuation of Amarastesia?
The current valuation of Amarastesia is .
-
What is Amarastesia’s current revenue?
The current revenue for Amarastesia is .
-
How much funding has Amarastesia raised over time?
Amarastesia has raised $50K.
-
Who are Amarastesia’s investors?
Innosuisse, Basel Area Business & Innovation, InnovX (Bucharest), DayOne Accelerator, and CNY Biotech Accelerator have invested in Amarastesia.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
